Opus Genetics IRD Warrant financing costs
Warrant financing costs at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept ird:WarrantFinancingCostsReclassifiedToFinancingActivities.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's warrant financing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's warrant financing costs?
- Opus Genetics (IRD) reported warrant financing costs of $0 in Q1 2026.
- How has Opus Genetics's warrant financing costs changed year-over-year?
- Opus Genetics's warrant financing costs decreased by 100.0% year-over-year, from $1.37M to $0.
- What does warrant financing costs mean?
- Captures costs associated with the issuance or modification of warrants that are initially recognized in operating activities but reclassified to financing activities. This metric helps investors isolate the true cash impact of capital-raising activities from core operational expenses. It is essential for understanding the total cost of equity-linked financing.